Content and interpretation of the conceptual apparatus of risk management project

Por A. V. Pochivalov, A. V. Sysolyatin
Publicado em 2021-09-01

A new analgesic agent based on hexaazaisowurzitan: feasibility of using in managing patients with cancer

Por K. A. Lopatina, S. G. Krylova, E. A. Safonova, E. P. Zueva, D. A. Kulagina, А. A. Churin, T. I. Fomina, S. V. Sysolyatin
Publicado em 2020-04-01

Risk of developing drug abuse in administration of a new hexaazaisowurtzitane derivative-based analgesic (experimental study)

Por S. G. Krylova, T. N. Pove’teva, K. A. Lopatina, Yu. V. Nesterova, E. P. Zueva, O. G. Afanas’eva, P. V. Kulpin, E. A. Kiseleva, N. I. Suslov, D. A. Kulagina, S. V. Sysolyatin, V. V. Zhdanov
Publicado em 2022-04-01

Analgesic action of hexaazaisowurtzitane derivative in somatic pain models caused by TRPA1 and TRPV1 Ion channels activation

Por S. G. Krylova, K. A. Lopatina, E. P. Zueva, E. A. Safonova, T. N. Povet’eva, Yu. V. Nesterova, O. G. Afanas’eva, P. V. Kul’pin, N. I. Suslov, D. A. Kulagina, S. V. Sysolyatin, V. V. Zhdanov
Publicado em 2021-01-01

Mouse-adapted influenza B virus for in vitro and in vivo assessment of therapeutic and preventive efficacy of antiviral drugs

Por E. A. Prokopyeva, O. G. Kurskaya, M. V. Solomatina, I. A. Sobolev, Т. A. Murashkina, А. A. Derko, K. V. Korchagina, A. Yu. Yunusova, A. Yu. Alekseev, A. М. Shestopalov, S. V. Sysolyatin, A. В. Vorozhtsov, О. Е. Vaizova, E. Yu. Sherstoboev, К. A. Sharshov, А. М. Dygai
Publicado em 2019-12-01